Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antivirals/HIV”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00000712
What this trial is testing

A Multicenter, Double Blind, Comparative Study of Zidovudine Alone Versus Zidovudine and Acyclovir as Treatment for HIV-Infected Patients With CD4+ Counts Less Than 200 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 400
Testing effectiveness (Phase 2)Study completedNCT00594880
What this trial is testing

Antiviral Activity of Peg-IFN-Alpha-2A in Chronic HIV-1 Infection

Who this might be right for
HIV Infections
The Wistar Institute 23
Post-approval studies (Phase 4)Study completedNCT02938013
What this trial is testing

DeLIVER: Direct Acting Antiviral Effects on the Liver

Who this might be right for
HCV CoinfectionLiver DiseaseHIV
Johns Hopkins University 15
Early research (Phase 1)Study completedNCT00000988
What this trial is testing

BMY-27857 in Patients With AIDS or AIDS Related Complex

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 40
Early research (Phase 1)Study completedNCT02463227
What this trial is testing

Evaluating the Safety, Pharmacokinetics, and Antiviral Activity of a Human Monoclonal Antibody (VRC01) in HIV-Infected Adults Undergoing a Brief Treatment Interruption

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 14
Post-approval studies (Phase 4)Study completedNCT00447070
What this trial is testing

Effect of Atazanavir on Endothelial Function in HIV-Infected Patients

Who this might be right for
HIV InfectionsDyslipidemia
Foundation for Cardiovascular Research, Zurich 50
Testing effectiveness (Phase 2)Study completedNCT00121979
What this trial is testing

Study Comparing Racivir and Lamivudine in Treatment-Experienced HIV Subjects

Who this might be right for
HIV Infections
Pharmasset 60
Large-scale testing (Phase 3)Study completedNCT02472886
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir in Adults With Chronic HCV Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 153
Not applicableStudy completedNCT05388474
What this trial is testing

A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab

Who this might be right for
HIV InfectionsMulti-Antiviral Resistance
Theratechnologies 168
Not applicableStudy completedNCT00002108
What this trial is testing

3TC (Lamivudine; GR109714X) Open-Label Program

Who this might be right for
HIV Infections
Glaxo Wellcome
Not applicableStudy completedNCT00002142
What this trial is testing

An Open-Label Study of the Safety and Efficacy of Cidofovir for the Treatment of Relapsing Cytomegalovirus Retinitis in Patients With AIDS

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Gilead Sciences 100
Early research (Phase 1)Looking for participantsNCT07392372
What this trial is testing

A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV

Who this might be right for
HIV -1 Infection
BioNTech SE 67
Testing effectiveness (Phase 2)UnknownNCT04819347
What this trial is testing

Albuvirtide in Combination With 3BNC117 in Virologically Suppressed Subjects With HIV-1 Infection

Who this might be right for
HIV/AIDS
Frontier Biotechnologies Inc. 24
Early research (Phase 1)Study completedNCT02275065
What this trial is testing

Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Bictegravir (GS-9883) in Human Immunodeficiency Virus (HIV)-1 Infected Participants

Who this might be right for
HIV-1 Infection
Gilead Sciences 23
Large-scale testing (Phase 3)Ended earlyNCT01923311
What this trial is testing

Two Part Study to Evaluate Pharmacokinetics, Safety, and Antiviral Activity of Elvitegravir Administered With a PI/r Background Regimen for ARV Treatment-Experienced Pediatric Participants

Who this might be right for
Acquired Immune Deficiency Syndrome (AIDS)HIV Infections
Gilead Sciences 31
Large-scale testing (Phase 3)Study completedNCT00002320
What this trial is testing

A Comparison of Lamivudine and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Not Used Zidovudine in the Past

Who this might be right for
HIV Infections
Glaxo Wellcome 320
Large-scale testing (Phase 3)Study completedNCT00005918
What this trial is testing

Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients

Who this might be right for
HIV Infections
Bristol-Myers Squibb 730
Testing effectiveness (Phase 2)Study completedNCT03045861
What this trial is testing

Safety and Efficacy Study of GSK2838232 in Human Immunodeficiency Virus (HIV)-1 Infected Adults

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
GlaxoSmithKline 33
Testing effectiveness (Phase 2)Study completedNCT01504841
What this trial is testing

Evaluating the Safety and Tolerability of Etravirine in HIV-1 Infected Infants and Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 26
Early research (Phase 1)Study completedNCT00518297
What this trial is testing

DDI HV (ATV - Merck)

Who this might be right for
HIV Infections
Bristol-Myers Squibb 22
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation